GlassScriptPhysician profile
Fawwaz Hamati
NPI 1225023104
$51,305.41
in general payments reported to CMS, 2019-2025
43 companies · $6,215 in 2025
The $6,215 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,337 · 2020: $4,236 · 2021: $6,443 · 2022: $5,267 · 2023: $9,042 · 2024: $11K · 2025: $6,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,720.78 |
| Food and Beverage | $11,302.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,436.60 | 2021-2025 | Corevalve Evolut R, Turbohawk, Evera Mri Xt Dr Surescan |
| Boston Scientific Corporation | $8,404.75 | 2019-2025 | Ekosonic, Avvigo Guidance System, Watchman Access System |
| Abiomed | $4,425.71 | 2019-2025 | Impella |
| Abbott Laboratories | $3,745.27 | 2019-2025 | Supera, Triclip, Perclose Proglide |
| Cardiovascular Systems INC. | $2,513.08 | 2019-2023 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $2,259.19 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,947.24 | 2019-2025 | |
| Terumo Medical Corporation | $1,321.03 | 2019 | |
| Baylis Medical Company INC | $1,303.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,192.17 | 2019-2025 | Farxiga, Brilinta |
| Penumbra, INC. | $1,102.12 | 2022-2024 | Indigo System, Smart Coil, Penumbra System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $850.41 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $777.17 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $506.06 | 2019-2024 | (Bq9) Coronary Ivus, (6586) Pioneer, (6536) Phoenix |
| Shockwave Medical, INC | $408.16 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fawwaz Hamati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.